Concepedia

María‐José Moreno

MM

Statistics

Publications

22

Citations

1K

H-Index

16

Active since

2001

Affiliations

Hospital Clínico Universitario Virgen de la Victoria(Current)

Hospital de Sant Pau

Hospital Clínico Universitario de Valencia

Hospital Universitari Germans Trias i Pujol

Hospital Universitario Central de Asturias

María‐José Moreno is an author at Hospital Clínico Universitario Virgen de la Victoria specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2001–2021

22

Publications

22

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 253 citations · Full text

, , +17

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

Josep‐María Ribera, Albert Oriol, Concepción Bethencourt et al. · PubMed · 2005 · 168 citations

, , +14

High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma

Albert Oriol, Josep‐María Ribera, Juan Bergua et al. · Cancer · 2008 · 126 citations · Full text

, , +13

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · Journal of Clinical Oncology · 2006 · 55 citations

, , +17

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · PubMed · 2002 · 46 citations

, , +17

1–5 of 22